title: Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook.
authors.affiliation: Department of Medicine, Division of Cardiovascular Medicine, Duke University Medical Center, Durham, NC.
authors.forename: E Magnus
authors.initials: EM
authors.lastname: Ohman
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Roe
mesh_terms: D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D000068799:Prasugrel Hydrochloride / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D010975:Platelet Aggregation Inhibitors; D000068799:Prasugrel Hydrochloride